Cargando…

Integrated (64)Cu therapy for the peritoneal dissemination of gastrointestinal cancer

Detalles Bibliográficos
Autor principal:	Kurihara, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2018
Materias:	News
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6101283/ https://www.ncbi.nlm.nih.gov/pubmed/30131842 http://dx.doi.org/10.18632/oncotarget.25840

Ejemplares similares

In Vitro Tumor Cell-Binding Assay to Select High-Binding Antibody and Predict Therapy Response for Personalized (64)Cu-Intraperitoneal Radioimmunotherapy against Peritoneal Dissemination of Pancreatic Cancer: A Feasibility Study
por: Hihara, Fukiko, et al.
Publicado: (2022)

Integrated treatment using intraperitoneal radioimmunotherapy and positron emission tomography-guided surgery with (64)Cu-labeled cetuximab to treat early- and late-phase peritoneal dissemination in human gastrointestinal cancer xenografts
por: Yoshii, Yukie, et al.
Publicado: (2018)

Targeting AURKA in treatment of peritoneal tumor dissemination in gastrointestinal cancer
por: Ozawa, Hiroki, et al.
Publicado: (2021)

Gastrointestinal stromal tumor coexisting with disseminated peritoneal leiomyomatosis
por: Akamine, Kenri, et al.
Publicado: (2019)

Comparison of the Effects of DOTA and NOTA Chelators on (64)Cu-Cudotadipep and (64)Cu-Cunotadipep for Prostate Cancer
por: Lee, Inki, et al.
Publicado: (2023)

Radionuclide Cisternography with [(64)Cu]Cu-DOTA
por: Greiser, Julia, et al.
Publicado: (2023)

A surprising Twist to cell dissemination
por: Short, Ben
Publicado: (2014)

(64)Cu-ATSM/(64)Cu-Cl(2) and their relationship to hypoxia in glioblastoma: a preclinical study
por: Pérès, Elodie A., et al.
Publicado: (2019)

In vivo quantitative assessment of therapeutic response to bortezomib therapy in disseminated animal models of multiple myeloma with [(18)F]FDG and [(64)Cu]Cu-LLP2A PET
por: Ghai, Anchal, et al.
Publicado: (2021)

ET-7 EVALUATION OF HYPOXIA-TARGETING RADIOPHARMACEUTICAL(64)CU-ATSM FOR PET MONITORING WITH LOCAL THERAPY IN HIGH-GRADE GLIOMA MODEL
por: Yoshii, Yukie, et al.
Publicado: (2022)

Chelator-Free (64)Cu-Integrated Gold Nanomaterials for Positron Emission Tomography Imaging Guided Photothermal Cancer Therapy
por: Sun, Xiaolian, et al.
Publicado: (2014)

Recent Advances in (64)Cu/(67)Cu-Based Radiopharmaceuticals
por: Krasnovskaya, Olga O., et al.
Publicado: (2023)

An abbreviated therapy-dosimetric equation for the companion diagnostic/therapeutic [(64/67)Cu]Cu-SARTATE
por: Laffon, Eric, et al.
Publicado: (2021)

Integrated fluorescent cytology with nano‐biologics in peritoneally disseminated gastric cancer
por: Watanabe, Megumi, et al.
Publicado: (2018)

MiR-signing gastrointestinal (con-)tract cancer
por: Gorgoulis, Vassilis G., et al.
Publicado: (2017)

(64)Cu-based Radiopharmaceuticals in Molecular Imaging
por: Zhou, Yeye, et al.
Publicado: (2019)

The use of a smartphone application to disseminate guidelines on pancreatic cystic neoplasms
por: Balduzzi, Alberto, et al.
Publicado: (2022)

Disseminated Peritoneal Leiomyomatosis
por: Momtahan, Mozhdeh, et al.
Publicado: (2011)

High Adhesion of Tumor Cells to Mesothelial Monolayers Derived from Peritoneal Wash of Disseminated Gastrointestinal Cancers
por: Ranieri, Danilo, et al.
Publicado: (2013)

Characterization and Stabilization of a New (64)Cu-Labeled Anti-EGFR Antibody NCAB001 for the Early Detection of Pancreatic Cancer with Positron Emission Tomography
por: Matsumoto, Hiroki, et al.
Publicado: (2021)

(64)Cu-DOTA-trastuzumab PET imaging and HER2 specificity of brain metastases in HER2-positive breast cancer patients
por: Kurihara, Hiroaki, et al.
Publicado: (2015)

Multiple Administrations of (64)Cu-ATSM as a Novel Therapeutic Option for Glioblastoma: a Translational Study Using Mice with Xenografts
por: Yoshii, Yukie, et al.
Publicado: (2017)

Synthesis and evaluation of (64)Cu-radiolabeled NOTA-cetuximab ((64)Cu-NOTA-C225) for immuno-PET imaging of EGFR expression
por: Xu, Xiaoxia, et al.
Publicado: (2019)

Harnessing (64)Cu/(67)Cu for a theranostic approach to pretargeted radioimmunotherapy
por: Keinänen, Outi, et al.
Publicado: (2020)

Theragnostic (64)Cu/(67)Cu Radioisotopes Production With RFT-30 Cyclotron
por: Lee, Jun Young, et al.
Publicado: (2022)

[(64)Cu]Cu-DOTATATE PET metrics in the investigation of atherosclerotic inflammation in humans
por: Jensen, Jacob K., et al.
Publicado: (2022)

The somatostatin receptor 2 antagonist (64)Cu-NODAGA-JR11 outperforms (64)Cu-DOTA-TATE in a mouse xenograft model
por: Rylova, Svetlana N., et al.
Publicado: (2018)

(64)Cu-ATSM and (18)FDG PET uptake and (64)Cu-ATSM autoradiography in spontaneous canine tumors: comparison with pimonidazole hypoxia immunohistochemistry
por: Hansen, Anders E, et al.
Publicado: (2012)

Peritoneal dissemination of breast cancer diagnosed by laparoscopy
por: Nakagawa, Tsuyoshi, et al.
Publicado: (2020)

The integrating nutritional therapy in oncology (INTO) project: rationale, structure and preliminary results
por: Caccialanza, Riccardo, et al.
Publicado: (2017)

Statistical Account of Cases Admitted into the Clinique of M. Velpeau at La Charité, during the Year 1863-64
por: Burlaud,, et al.
Publicado: (1864)

Towards integration of (64)Cu-DOTA-trastuzumab PET-CT and MRI with mathematical modeling to predict response to neoadjuvant therapy in HER2 + breast cancer
por: Jarrett, Angela M., et al.
Publicado: (2020)

Imaging Neurotensin Receptor in Prostate Cancer With (64)Cu-Labeled Neurotensin Analogs
por: Deng, Huaifu, et al.
Publicado: (2017)

Gastrointestinal Guidelines app: Streamlining guideline awareness and adherence in gastroenterology
por: Balduzzi, Alberto, et al.
Publicado: (2023)

Effect of intratumoral administration on biodistribution of (64)Cu-labeled nanoshells
por: Xie, Huan, et al.
Publicado: (2012)

Pilot Study of (64)Cu(I) for PET Imaging of Melanoma
por: Jiang, Lei, et al.
Publicado: (2017)

(64)Cu-DOTATOC PET-CT in Patients with Neuroendocrine Tumors
por: Mirzaei, Siroos, et al.
Publicado: (2019)

Effect of Liraglutide on Vascular Inflammation Evaluated by [(64)Cu]DOTATATE
por: Zobel, Emilie H., et al.
Publicado: (2021)

Autotaxin in ascites promotes peritoneal dissemination in pancreatic cancer
por: Jinno, Naruomi, et al.
Publicado: (2020)

Giant gastric gastrointestinal stromal tumor with severe peritoneal dissemination controlled by imatinib therapy following debulking surgery: a case report
por: Fukuda, Shuichi, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_9nphriqg5ull9k3hor3psfd66s